FREDERICK, Md.–(BUSINESS WIRE)–Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for VLX-1005 for the treatment of heparin induced thrombocytopenia (HIT). ...  Read more

Vision Technologies, Inc. (Vision), a leading systems integrator announces that it has been successfully reappraised at Level 3 of the new CMMI® Institute’s Capability Maturity Model Integration for Services (CMMI-SVC) version 2.0. CMMI is a capability improvement framework providing organizations with the essential elements of effective processes that ultimately improve their performance. Vision’s practices consistently provide high-quality results using CMMI principles. ...  Read more

Vision Technologies, Inc. (Vision), a leading systems integrator, has been awarded an In-Building Cellular Solutions contract by the United States Postal Service. ...  Read more

Rothwell Figg is proud to announce its new blog, RF EMerge, (www.RFEMerge.com), a resource for emerging companies that provides insight and updates on common challenges faced, pertinent industry trends and analysis, and key legal developments affecting innovators. ...  Read more

GLEN BURNIE, MD, December 15, 2020 – Vision Technologies, Inc. (Vision), a leading network integrator with national and global reach, announces an innovative way to consume integrated technology solutions as a service. The Technology as a Services (TaaS) solution is a monthly subscription-based agreement that encompasses the design, build and support. These services allow businesses to focus on their mission instead of worrying about the technology or upfront capital needed to secure work environments. ...  Read more